RR
Rashmi Ranjan Behera
About Rashmi Ranjan Behera
Data last updated:
Rashmi Ranjan Behera is a Director at Jixon Pharmaceuticals Private Limited (since 2017). The companies operate in Pharma and Chemicals. Jixon Pharmaceuticals Private Limited reported revenue of ₹1.22 Cr (FY 2023). Earlier, Rashmi Ranjan Behera was a Director at Senberk Pharmaceuticals Private Limited (2015–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Sep 2017 | 2016 | ₹1.22 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jan 2015 | 2015 | ₹32.5 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rashmi Ranjan Behera
| Name | DIN | Company | Designation |
|---|---|---|---|
| Surendra Kumar Behera | 07552848 | Jixon Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rashmi Ranjan Behera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rashmi Ranjan Behera
Rashmi Ranjan Behera currently holds 1 directorship: Jixon Pharmaceuticals Private Limited (Director, since 29 Sep 2017, revenue ₹1.22 Cr (FY 2023)).
Rashmi Ranjan Behera was first appointed on 20 Jan 2015 as Director at Senberk Pharmaceuticals Private Limited. The most recent appointment on record is 29 Sep 2017 at Jixon Pharmaceuticals Private Limited.
Rashmi Ranjan Behera held 1 earlier board appointment: Senberk Pharmaceuticals Private Limited (Director, 20 Jan 2015 to 30 Jan 2017).
The current boards of Rashmi Ranjan Behera's companies include Surendra Kumar Behera (Jixon Pharmaceuticals Private Limited).